Genius Sports Limited — Form 6-K Summary
Filing date: December 20, 2022. This Form 6-K reports amendments to the company’s solicitation of warrant-holder consents, initiated November 18, 2022. It is not a periodic financial-results filing and does not provide revenue, earnings, cash flow, margin, debt, or liquidity figures.
Business Context and Transaction
Genius Sports amended and restated the terms of its solicitation seeking consent from warrant holders to amend the warrant agreement originally entered into by dMY Technology Group II and assumed by Genius Sports in April 2021.
The proposed amendment would cause warrants not exercised by the expiration date to be automatically exercised on a cashless basis, subject to the stated conditions. If approved, all warrants would be exercised and cease to exist, and warrant trading on the NYSE would end.
Key Terms
- Expiration date: 11:59 p.m. Eastern Time on January 19, 2023, unless extended.
- Reduced exercise price: 74% of the volume-weighted average price of Genius Sports ordinary shares for the expected January 17, 2023 trading day, if that price is below $11.50 per share.
- Cashless exercise during the consent period: Holders exercising under the reduced-price terms would receive 0.260 ordinary shares per warrant.
- Automatic post-expiration exercise: Warrants not otherwise exercised would be exercised automatically on a cashless basis at an exercise price equal to 76.6% of the applicable volume-weighted average price, if that price is below $11.50 per share, with holders receiving 0.234 ordinary shares per warrant.
- Existing terms: Before expiration, holders may continue to exercise warrants under the existing warrant agreement at $11.50 per share.
Material Changes and Conditions
- The company reduced the proposed exercise price from the existing $11.50 to the specified 74% of the applicable volume-weighted average price, subject to the price condition.
- The company entered into a Cashless Exercise Amendment giving warrant holders the option to exercise on a cashless basis during the consent period.
- The reduced exercise price and cashless exercise amendment are conditioned on obtaining the requisite consents for the warrant amendment, although the company may waive that condition in its sole discretion.
- Any consents submitted before the December 20, 2022 filing of Amendment No. 1 to the Form F-4 registration statement will not be accepted; holders must resubmit consent after that filing and before expiration.
- The solicitation is conditioned on the effectiveness of the Form F-4 registration statement, and the dates and periods may be extended or modified.
Financial Metrics, Outlook, and Risks
The filing contains no operating results, financial guidance, liquidity analysis, debt information, or management commentary regarding business performance. Key transaction risks include the possibility that the required consents or registration statement effectiveness are not obtained, that dates are extended, and that the final exercise price depends on the applicable future share-price average.
Important Facts for Investors to Verify
- Whether the required warrant-holder consents were obtained and whether the warrant amendment became effective.
- Whether the Form F-4 registration statement became effective.
- The final expiration date and the applicable volume-weighted average share price used to calculate the reduced exercise price.
- The number of warrants exercised, the resulting ordinary-share issuance, and any related dilution.
- Whether the warrants ceased trading on the NYSE following completion of the process.
- The detailed terms in Exhibits 4.1, 4.2, and 99.1 and the related Form F-4, Schedule TO, prospectus, and consent materials.